Immunofluorescence showed that activation of Wnt/β-catenin signalling by Wnt3a promoted the expression of Vimentin, whereas blocking Wnt/β-catenin pathway by silencing β-catenin suppressed the mesenchymal marker in glioma cells (Figure 1E). The gene discussed is VIM; the disease is glioma.